DC
Voters
Overwhelmingly
Approve
Treatment
Not
Jail
Initiative
11/8/02
Tuesday didn't bring all
bad news. Though Ohio voters rejected a similar initiative, voters
in the nation's capital issued a broad mandate for drug treatment instead
of prison for nonviolent drug offenders. DC's Measure 62, organized
by the Drug Policy Alliance, passed by a whopping margin of 78% to 22%.
The measure had been opposed editorially by both the Washington Post and
the Washington Times, but otherwise saw no significant organized opposition.
With the passage of Measure
62, District residents charged with the possession of other than Schedule
I drugs will be able to opt for drug treatment in place of conviction or
imprisonment for illegal drug possession. All legal proceedings against
covered drug possession defendants would be dismissed upon completion of
drug treatment.
Schedule I drugs -- including
heroin, LSD, ecstasy, and marijuana -- are widely used in the District
and their users are often arrested, but campaign organizers told DRCNet
they were excluded because of fears of arousing congressional action against
any measure that would effectively reduce marijuana penalties.
While the DC campaign can
claim a rare victory for drug reform, the election victory is only the
beginning. Measure 62 supporters will have to gain funding to implement
the treatment program, and that funding will have to be approved by a GOP-controlled
Congress, whether it comes from local funds or federal. The measure
is set to become law on October 1 next year, and Measure 62 organizers
are already calling on supporters to build a broad coalition to ensure
funding and proper implementation. They have won a battle in DC,
but the war continues.
Visit http://www.dcmeasure62.com
to keep up with Measure 62.
-- END --
Issue #262, 11/8/02
Editorial: More to This Vote Than Meets the Eye | Black Tuesday for Drug Reform | Arizona Steps Back as Decrim Initiative Loses, Anti-Reform Sentencing Initiative Wins | Legal Pot in Nevada? Not This Year | New York: Pataki Victory Swamps Dems, Golisano, Marijuana Reform Party, Libertarians | Ohio "Treatment Not Jail" Initiative Runs Into Drug War Buzzsaw | No Hemp, No New Rights for Defendants in South Dakota | Wisconsin: Libertarian Thompson Gets Ten Percent | DC Voters Overwhelmingly Approve Treatment Not Jail Initiative | Massachusetts Voters Tell Reps to Support Marijuana Decrim | San Francisco Voters Ask City to Look at Growing Its Own | FAMM Victory: Amendment to Cap Federal Guideline Sentences for Low-Level Drug Offenders is Now Law | Colombian Campaign for Drug Legalization | Anti-Prohibitionists Meet Human Rights Advocates and Political Leaders at Albania Congress of Transnational Radical Party | Newsbrief: Nordic Prohibitionists Beginning Counter-Campaign Supporting UN Drug Conventions | Web Scan: Forbes on Hope Taft, Newsday on Tony Papa, New Scientist on Cannabis, Raich v. Ashcroft Lawsuit Docs | Action Alerts: Rave Bill, Medical Marijuana, Higher Education Act Drug Provision, Tulia, Salvia Divinorum | The Reformer's Calendar
|
This issue -- main page
This issue -- single-file printer version
Drug War Chronicle -- main page
Chronicle archives
|
PERMISSION to reprint or
redistribute any or all of the contents of Drug War Chronicle (formerly The Week Online with DRCNet is hereby
granted. We ask that any use of these materials include proper credit and,
where appropriate, a link to one or more of our web sites. If your
publication customarily pays for publication, DRCNet requests checks
payable to the organization. If your publication does not pay for
materials, you are free to use the materials gratis. In all cases, we
request notification for our records, including physical copies where
material has appeared in print. Contact: StoptheDrugWar.org: the Drug Reform Coordination Network,
P.O. Box 18402, Washington, DC 20036, (202) 293-8340 (voice), (202)
293-8344 (fax), e-mail [email protected]. Thank
you.
Articles of a purely
educational nature in Drug War Chronicle appear courtesy of the DRCNet
Foundation, unless otherwise noted.
|